Title : Successful transition from Treprostinil to Selexipag in patient with severe pulmonary arterial hypertension.

Pub. Date : 2017 Oct 26

PMID : 29073911






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSIONS: We report the first case of successful replacement of treprostinil (20.1 ng/kg/min) with selexipag (1600 mug BID) as a component of triple combination therapy, which provides incentive to perform a larger, prospective exchange study. selexipag BH3 interacting domain death agonist Homo sapiens